Pfizer Inc. (PFE)
NYSE: PFE · Real-Time Price · USD
23.97
+0.09 (0.38%)
At close: Jun 20, 2025, 4:00 PM
24.00
+0.03 (0.13%)
After-hours: Jun 20, 2025, 7:59 PM EDT
Pfizer Stock Forecast
Stock Price Forecast
The 14 analysts that cover Pfizer stock have a consensus rating of "Hold" and an average price target of $29.92, which forecasts a 24.82% increase in the stock price over the next year. The lowest target is $24 and the highest is $45.
Price Target: $29.92 (+24.82%)
Analyst Consensus: Hold
* Price targets were last updated on Apr 30, 2025.
Analyst Ratings
The average analyst rating for Pfizer stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
Rating | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 | Jun '25 |
---|---|---|---|---|---|---|
Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
Buy | 3 | 3 | 3 | 3 | 3 | 2 |
Hold | 8 | 8 | 8 | 9 | 9 | 9 |
Sell | 1 | 1 | 1 | 1 | 1 | 1 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 14 | 14 | 14 | 15 | 15 | 14 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
UBS | UBS | Hold Maintains $24 → $25 | Hold | Maintains | $24 → $25 | +4.30% | Apr 30, 2025 |
Cantor Fitzgerald | Cantor Fitzgerald | Hold Initiates $24 | Hold | Initiates | $24 | +0.13% | Apr 22, 2025 |
UBS | UBS | Hold Maintains $28 → $24 | Hold | Maintains | $28 → $24 | +0.13% | Apr 8, 2025 |
Goldman Sachs | Goldman Sachs | Strong Buy → Hold Downgrades $32 → $25 | Strong Buy → Hold | Downgrades | $32 → $25 | +4.30% | Apr 8, 2025 |
Guggenheim | Guggenheim | Strong Buy Reiterates n/a | Strong Buy | Reiterates | n/a | n/a | Mar 18, 2025 |
Financial Forecast
Revenue This Year
63.05B
from 63.63B
Decreased by -0.91%
Revenue Next Year
62.83B
from 63.05B
Decreased by -0.34%
EPS This Year
3.06
from 1.41
Increased by 116.94%
EPS Next Year
3.15
from 3.06
Increased by 3.00%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 67.2B | 67.4B | 67.6B | ||
Avg | 63.0B | 62.8B | 61.4B | ||
Low | 59.4B | 58.0B | 56.1B |
Revenue Growth
Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 5.5% | 6.9% | 7.5% | ||
Avg | -0.9% | -0.3% | -2.4% | ||
Low | -6.7% | -8.0% | -10.7% |
EPS Forecast
EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 3.50 | 3.64 | 3.85 | ||
Avg | 3.06 | 3.15 | 3.14 | ||
Low | 2.86 | 2.70 | 2.73 |
EPS Growth
EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 147.6% | 18.9% | 22.1% | ||
Avg | 116.9% | 3.0% | -0.4% | ||
Low | 102.7% | -12.0% | -13.3% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.